Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties

McCubrey, James A.Meher, Akshaya K.Akula, Shaw M.Abrams, Stephen L.Steelman, Linda S.LaHair, Michelle M.Franklin, Richard A.Martelli, Alberto M.Ratti, StefanoCocco, LucioBarbaro, FulvioDuda, PrzemysławGizak, Agnieszka2022-11-022022-11-022022-04-271945-4589http://hdl.handle.net/10342/11681en-USTP53pancreatic cancerdrug sensitivityWild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic PropertiesArticle10.18632/aging.204038